Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci +9 more
wiley +1 more source
Reinforcing properties of Pramipexole in normal and parkinsonian rats
Neurobiology of Disease, 2013 Striatal D2 and D3 dopamine receptors are involved in mediating the reinforcing properties of natural rewards and drugs. In Parkinson's disease, while D2/3 dopamine agonists alleviate motor symptoms, behavioral addictions and withdrawal syndrome are ...
Michel Engeln +5 more
doaj
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome. [PDF]
Sleep, 2022 Winkelman JW.
europepmc +1 more source
Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists [PDF]
, 2000 Neal R. Swerdlow +7 more
openalex +1 more source
Stroke Mimicking Thalamotomy in Primary Familial Brain Calcification
Movement Disorders Clinical Practice, EarlyView.
Jaakko Kungshamn +4 more
wiley +1 more source
Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers
Movement Disorders Clinical Practice, EarlyView.Abstract Background Real‐world evidence on treatment practices in Parkinson's disease (PD) has been limited due to the difficulty in collecting comprehensive and generalizable clinical data. Objectives We sought to identify treatment patterns and test how treatment changed in response to (1) falling, (2) worsening disease, and (3) worsening quality of ...
Nabila Dahodwala +11 more
wiley +1 more source
Journal of Pharmacological Sciences, 2003 : κ-Opioid receptor agonists decrease the levels of extracellular dopamine in vivo and in vitro. However, the mechanism(s) underlying these actions are unclear.
Nuannoi Chudapongse +3 more
doaj
Dopamine agonist responsive burning mouth syndrome: Report of eight cases. [PDF]
World J Clin Cases, 2021 Du QC, Ge YY, Xiao WL, Wang WF.
europepmc +1 more source
Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach
, 1990 Romain A. Lefebvre +2 more
openalex +2 more sources
Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients1 [PDF]
, 2000 Annamaria Colao +10 more
openalex +1 more source